Pharma channel feed

Bi­par­ti­san group of sen­a­tors calls for ways to im­prove 340B drug dis­count pro­gram

Last year

Cannes Li­ons en­tries for phar­ma, health & well­ness awards sig­nal re­turn to busi­ness as usu­al

Last year
Marketing

FDA ap­proves Roche’s sec­ond CD20xCD3 bis­pe­cif­ic in cer­tain lym­phomas

Last year
R&D

FDA de­lays de­ci­sion on GSK blood can­cer drug at heart of $1.9B Sier­ra On­col­o­gy deal

Last year
R&D

Con­gress in­tro­duces two new bills about PBM re­form, drug pric­ing

Last year
Law

Ab­b­Vie touts Skyrizi ul­cer­a­tive col­i­tis da­ta as it eyes an­oth­er in­di­ca­tion

Last year

No­vo Nordisk boosts an­ti-obe­si­ty stig­ma ef­forts with film and TV doc­u­men­tary part­ner­ships

Last year
Marketing

Ab­b­Vie steps up to the plate with MLB play­er for IBD aware­ness

Last year
Marketing

Co­herus and Ab­b­Vie set­tle Hu­mi­ra biosim­i­lar dis­pute af­ter Mark Cuban's Cost Plus Drugs an­nounce­ment

Last year

San­doz un­veils glob­al ac­tion plan to im­prove ac­cess to biosim­i­lars

Last year
FDA+

'Mod­er­na will be a rare dis­ease com­pa­ny,' CEO says, as mR­NA com­pa­ny plots ex­pan­sion in ge­net­ic dis­eases and eyes n-of-1 treat­ments

Last year
R&D
In Focus

Verve snags $60M from Lil­ly to tack­le Lp(a) with one-time gene edit­ing

Last year
Deals
Cell/Gene Tx

Mer­ck gets a patent win for mus­cle re­lax­ant re­ver­sal drug

Last year
Law

To restart com­mon can­cer drug pro­duc­tion short­ly, FDA work­ing close­ly with Ac­cord

Last year
FDA+
Manufacturing

Pep­Gen de­lays PhI study on my­oton­ic dy­s­tro­phy as it awaits more in­fo on clin­i­cal hold

Last year

Pfiz­er ad­ver­tis­ing com­mu­ni­ca­tions to Meta sub­poe­naed by state of Texas as part of pri­va­cy law­suit — re­port

Last year
Marketing

Astel­las CEO Nao­ki Oka­mu­ra says part­ner­ships 'crit­i­cal' to growth plans

Last year
People

Pfiz­er says peni­cillin in­jec­tion may soon be in short sup­ply

Last year
Manufacturing

Am­gen taps Mod­er­na vet Paul Bur­ton as new CMO

Last year
People

IRA side ef­fect: Phar­ma com­pa­nies will in­creas­ing­ly skip Medicare al­to­geth­er, Lil­ly CEO says

Last year
Law

Mer­ck steps in­to NASH space with ear­ly da­ta for its GLP-1/glucagon re­cep­tor co-ag­o­nist

Last year

$1 Dara­prim? Im­prim­is­Rx fa­cil­i­ty in New Jer­sey hit with FDA warn­ing let­ter

Last year
FDA+
Manufacturing

Bernie Sanders thinks the fed­er­al gov­ern­ment needs a bet­ter ROI on its drug R&D

Last year

Astel­las los­es patent in­fringe­ment case over block­buster blad­der drug

Last year
Law
First page Previous page 116117118119120121122 Next page Last page
A service from the Financial Times